CClinicalTrials.gg
CompletedNCT05319795Updated Jul 29, 2024Results posted

Effortful Swallow Maneuver for Swallowing Impairment in People With Parkinson Disease

An interventional study of Effortful Swallow Maneuver in Parkinson Disease and Dysphagia, sponsored by University Health Network, Toronto. Completed at 2 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-29.

Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Context: Many people with Parkinson Disease (PwPD) experience swallowing difficulties, particularly with food/liquid going down the wrong way or remaining in the throat after swallowing. Prior studies suggest that exercise-based treatments targeting swallowing strength may be effective in reducing these difficulties.

Research question: Does an exercise-based treatment involving the effortful swallow maneuver improve swallowing function in PwPD?

Study plan: The investigators will study the effects of a four-week intensive swallowing rehabilitation program in PwPD, over a 2-year period.

Read the detailed description

The investigators will study the effects of a four-week intensive swallowing rehabilitation program in PwPD, over a 2 year period. The program will involve daily practice of the effortful swallowing maneuver, with swallowing function assessed before and after the treatment program using videofluoroscopic x-rays.

Expected outcomes: In other populations, the effortful swallow has shown to address two mechanisms that are thought to underlie swallowing impairment in Parkinson Disease: slowness in achieving airway protection and weakness in muscles responsible for transporting food through the throat. The investigators expect that repeated practice of this maneuver by PwPD will lead to improved airway protection and improved clearance of residue from the throat.

02

Conditions studied

  • Parkinson Disease
  • Dysphagia

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 5 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University Health Network, Toronto is the lead sponsor of 1,411 studies on the registry; 292 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • At least 18 years old
  • English-speaking
  • Able to follow study instructions
  • Neurologist confirmed diagnosis of PD
  • Hoehn and Yahr scale score of 2 or 3
  • Self-report of one or more swallowing or related symptoms:

    1. Difficulty with secretion management
    2. Coughing at the meal time
    3. Choking on food
    4. Respiratory infection in the past 6 months (other than COVID)

Exclusion criteria

Exclusion Criteria:

  • History of head and neck cancer
  • Radical neck dissection (e.g. anterior cervical spine surgery) or neck/ oropharyngeal surgery (not excluded - tonsillectomy, adenoidectomy)
  • Past medical history of any neurological disease other than PD (e.g. multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, stroke)
  • Cognitive or receptive communication difficulties that preclude the participant's ability to follow study instructions provided in English. This will be determined by the participant's physician prior to referring them to the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Effortful Swallow Maneuver

    Adults with a confirmed diagnosis of Parkinson Disease who have radiographically confirmed difficulties with timely airway protection and/or bolus clearance during swallowing. Individuals will complete a 4-week intervention program with two 30-minute sessions of Effortful Swallow (ES) practice daily, 5 days per week.

    Behavioral: Effortful Swallow Maneuver

Interventions

  • BehavioralEffortful Swallow Maneuver

    Repeated practice of the Effortful Swallowing Maneuver generated by pushing the tongue with increased effort against the palate at the point of swallow initiation.

06

What researchers measure

Primary outcomes

  1. Change in Time-to-laryngeal-vestibule-closure Thin Liquids

    The time interval (in milliseconds) measured on a videofluoroscopic x-ray of swallowing between onset of the hyoid burst movement at the beginning of a swallow and achieving airway protection via closure of the laryngeal vestibule. The investigators will measure time-to-laryngeal-vestibule-closure across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. longest) across these 3 task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  2. Change in Penetration-Aspiration Scale Score Thin Liquids

    The Penetration-Aspiration Scale is an 8-point ordinal scale, measured on a videofluorosopic x-ray of swallowing, which documents the depth of any airway invasion events, and the subsequent response to airway invasion (Rosenbek et al., 1996). The scale ranges from a minimum score of 1 (no airway invasion) to a maximum score of 8 (entry of material below the true vocal folds with no response and no ejection). Higher scores are worse. The investigators will measure penetration-aspiration across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. highest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  3. Change in Pharyngeal Area at Maximum Constriction Thin Liquids

    A videofluoroscopic measure of the degree of pharyngeal constriction during swallowing (i.e. maximum obliteration of the space in the pharynx). This measure is obtained from pixel-based measures of the unobliterated area of the pharynx on a lateral view x-ray image at the point of maximum constriction. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal area at maximum constriction across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  4. Change in Total Pharyngeal Residue Thin Liquids

    A videofluoroscopic measure of the amount of residue left behind in the pharynx after a swallow. This measure is obtained from pixel-based measures of the area of residue in the pharynx on a lateral view x-ray image at the end of the swallow. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal residue across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  5. Change in Time-to-laryngeal-vestibule-closure Mildly Thick Liquids

    The time interval (in milliseconds) measured on a videofluoroscopic x-ray of swallowing between onset of the hyoid burst movement at the beginning of a swallow and achieving airway protection via closure of the laryngeal vestibule. The investigators will measure time-to-laryngeal-vestibule-closure across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. longest) across these 3 task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  6. Change in Penetration-Aspiration Scale Score Mildly Thick Liquids

    The Penetration-Aspiration Scale is an 8-point ordinal scale, measured on a videofluorosopic x-ray of swallowing, which documents the depth of any airway invasion events, and the subsequent response to airway invasion (Rosenbek et al., 1996). The scale ranges from a minimum score of 1 (no airway invasion) to a maximum score of 8 (entry of material below the true vocal folds with no response and no ejection). Higher scores are worse. The investigators will measure penetration-aspiration across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. highest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  7. Change in Pharyngeal Area at Maximum Constriction Mildly Thick Liquids

    A videofluoroscopic measure of the degree of pharyngeal constriction during swallowing (i.e. maximum obliteration of the space in the pharynx). This measure is obtained from pixel-based measures of the unobliterated area of the pharynx on a lateral view x-ray image at the point of maximum constriction. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal area at maximum constriction across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

  8. Change in Total Pharyngeal Residue Mildly Thick Liquids

    A videofluoroscopic measure of the amount of residue left behind in the pharynx after a swallow. This measure is obtained from pixel-based measures of the area of residue in the pharynx on a lateral view x-ray image at the end of the swallow. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal residue across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

    Time frame: Post treatment (4 weeks) compared to pre-treatment baseline

07

Results

Posted Jul 29, 2024

Participant flow

Participant flow — Overall Study
MilestoneEffortful Swallow Maneuver
Started5
Completed5
Not completed0

Outcome measures

PrimaryChange in Time-to-laryngeal-vestibule-closure Thin Liquids

The time interval (in milliseconds) measured on a videofluoroscopic x-ray of swallowing between onset of the hyoid burst movement at the beginning of a swallow and achieving airway protection via closure of the laryngeal vestibule. The investigators will measure time-to-laryngeal-vestibule-closure across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. longest) across these 3 task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · milliseconds
Change in Time-to-laryngeal-vestibule-closure Thin Liquids
millisecondsEffortful Swallow Maneuver
Change in Time-to-laryngeal-vestibule-closure Thin Liquids0 ± 132
PrimaryChange in Penetration-Aspiration Scale Score Thin Liquids

The Penetration-Aspiration Scale is an 8-point ordinal scale, measured on a videofluorosopic x-ray of swallowing, which documents the depth of any airway invasion events, and the subsequent response to airway invasion (Rosenbek et al., 1996). The scale ranges from a minimum score of 1 (no airway invasion) to a maximum score of 8 (entry of material below the true vocal folds with no response and no ejection). Higher scores are worse. The investigators will measure penetration-aspiration across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. highest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · score on a scale
Change in Penetration-Aspiration Scale Score Thin Liquids
score on a scaleEffortful Swallow Maneuver
Change in Penetration-Aspiration Scale Score Thin Liquids0 ± 1
PrimaryChange in Pharyngeal Area at Maximum Constriction Thin Liquids

A videofluoroscopic measure of the degree of pharyngeal constriction during swallowing (i.e. maximum obliteration of the space in the pharynx). This measure is obtained from pixel-based measures of the unobliterated area of the pharynx on a lateral view x-ray image at the point of maximum constriction. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal area at maximum constriction across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · percentage of the C2-4 anatomical scalar
Change in Pharyngeal Area at Maximum Constriction Thin Liquids
percentage of the C2-4 anatomical scalarEffortful Swallow Maneuver
Change in Pharyngeal Area at Maximum Constriction Thin Liquids-.12 ± 2.5
PrimaryChange in Total Pharyngeal Residue Thin Liquids

A videofluoroscopic measure of the amount of residue left behind in the pharynx after a swallow. This measure is obtained from pixel-based measures of the area of residue in the pharynx on a lateral view x-ray image at the end of the swallow. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal residue across a series of 3 thin liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · percentage of the C2-4 anatomical scalar
Change in Total Pharyngeal Residue Thin Liquids
percentage of the C2-4 anatomical scalarEffortful Swallow Maneuver
Change in Total Pharyngeal Residue Thin Liquids-.24 ± 1.29
PrimaryChange in Time-to-laryngeal-vestibule-closure Mildly Thick Liquids

The time interval (in milliseconds) measured on a videofluoroscopic x-ray of swallowing between onset of the hyoid burst movement at the beginning of a swallow and achieving airway protection via closure of the laryngeal vestibule. The investigators will measure time-to-laryngeal-vestibule-closure across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. longest) across these 3 task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · milliseconds
Change in Time-to-laryngeal-vestibule-closure Mildly Thick Liquids
millisecondsEffortful Swallow Maneuver
Change in Time-to-laryngeal-vestibule-closure Mildly Thick Liquids33 ± 198
PrimaryChange in Penetration-Aspiration Scale Score Mildly Thick Liquids

The Penetration-Aspiration Scale is an 8-point ordinal scale, measured on a videofluorosopic x-ray of swallowing, which documents the depth of any airway invasion events, and the subsequent response to airway invasion (Rosenbek et al., 1996). The scale ranges from a minimum score of 1 (no airway invasion) to a maximum score of 8 (entry of material below the true vocal folds with no response and no ejection). Higher scores are worse. The investigators will measure penetration-aspiration across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. highest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · score on a scale
Change in Penetration-Aspiration Scale Score Mildly Thick Liquids
score on a scaleEffortful Swallow Maneuver
Change in Penetration-Aspiration Scale Score Mildly Thick Liquids-1 ± 2
PrimaryChange in Pharyngeal Area at Maximum Constriction Mildly Thick Liquids

A videofluoroscopic measure of the degree of pharyngeal constriction during swallowing (i.e. maximum obliteration of the space in the pharynx). This measure is obtained from pixel-based measures of the unobliterated area of the pharynx on a lateral view x-ray image at the point of maximum constriction. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal area at maximum constriction across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · percentage of the C2-4 anatomical scalar
Change in Pharyngeal Area at Maximum Constriction Mildly Thick Liquids
percentage of the C2-4 anatomical scalarEffortful Swallow Maneuver
Change in Pharyngeal Area at Maximum Constriction Mildly Thick Liquids.28 ± 1.5
PrimaryChange in Total Pharyngeal Residue Mildly Thick Liquids

A videofluoroscopic measure of the amount of residue left behind in the pharynx after a swallow. This measure is obtained from pixel-based measures of the area of residue in the pharynx on a lateral view x-ray image at the end of the swallow. The number of pixels is divided by an anatomical reference scalar defined by the squared length of the distance, in pixels, between the anterior inferior corners of the C2 and C4 cervical vertebrae on the same image. The investigators will measure pharyngeal residue across a series of 3 mildly thick liquid swallows in videofluoroscopy. The participant's worst score (i.e. largest) across these three task repetitions will be recorded at each timepoint and the difference across timepoints will be calculated.

Time frame:
Post treatment (4 weeks) compared to pre-treatment baseline
Reported as:
Mean · percentage of the C2-4 anatomical scalar
Change in Total Pharyngeal Residue Mildly Thick Liquids
percentage of the C2-4 anatomical scalarEffortful Swallow Maneuver
Change in Total Pharyngeal Residue Mildly Thick Liquids-.5 ± 1.07

Adverse events

Collected over During the time frame between baseline and post 4-week treatment. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Effortful Swallow Maneuver0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Effortful Swallow Maneuver
Mean70 (63 to 74)
Sex: Female, Male
Sex: Female, Male(Participants)Effortful Swallow Maneuver
Female2
Male3
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Effortful Swallow Maneuver
Hispanic or Latino0
Not Hispanic or Latino5
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Effortful Swallow Maneuver
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White5
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Effortful Swallow Maneuver
Canada5
08

Study locations

2 sites
  • Toronto Rehabilitation Institute - University Health Network
    Toronto, Ontario M5G 2A2, Canada
  • University Health Network
    Toronto, Ontario M5G 2C4, Canada
09

References and documents

Publications

  • Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996 Spring;11(2):93-8. doi: 10.1007/BF00417897. PubMed 8721066 ↗

Study documents

  • Protocol and statistical analysis plan · Jan 14, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05319795
Lead sponsor
University Health Network, Toronto
Responsible party
Catriona Steele (Scientist, University Health Network, Toronto) — Principal investigator
First posted
Apr 8, 2022
Start date
Mar 9, 2022
Primary completion
Jun 5, 2023
Completion
Jun 5, 2023
Results posted
Jul 29, 2024
Last update
Jul 29, 2024

Study contacts

Catriona M Steele, PhD
principal investigator · University Health Network, Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion